| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/07/2009 | US20090118259 Pharmaceutical use of substituted amides |
| 05/07/2009 | US20090118258 Combination therapy comprising angiotensin converting enzyme inhibitors and vasopressin receptor antagonists |
| 05/07/2009 | US20090118257 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES |
| 05/07/2009 | US20090118256 Chronotherapeutic diltiazem formulations and the administration thereof |
| 05/07/2009 | US20090118255 Crp Lowering Agent |
| 05/07/2009 | US20090118254 Histamine h3 receptor agents, preparation and therapeutic uses |
| 05/07/2009 | US20090118253 Compositions and methods for treating dysfunctional uterine bleeding |
| 05/07/2009 | US20090118252 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/07/2009 | US20090118251 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/07/2009 | US20090118250 Pharmaceutical composition |
| 05/07/2009 | US20090118249 Dheas inhalation compositions |
| 05/07/2009 | US20090118248 3-Alpha-hydroxy 21-n-heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof |
| 05/07/2009 | US20090118247 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| 05/07/2009 | US20090118246 Therapeutic ophthalmic compositions containing retinal friendly recpients and related methods |
| 05/07/2009 | US20090118245 Medicament |
| 05/07/2009 | US20090118244 Benzodiazepinone compounds useful in the treatment of skin conditions |
| 05/07/2009 | US20090118243 Compositions and methods for the treatment of ophthalmic conditions |
| 05/07/2009 | US20090118242 Injectable capsaicin with non-steroidal anti-inflammatory adjunctive agent |
| 05/07/2009 | US20090118241 Bioabsorbable polymer compositions exhibiting enhanced crystallization and hydrolysis rates |
| 05/07/2009 | US20090118240 Local treatment of neurofibromas |
| 05/07/2009 | US20090118239 Amorphous and crystalline forms of ibandronate disodium |
| 05/07/2009 | US20090118238 Deuterium-enriched alendronate |
| 05/07/2009 | US20090118237 Carisoprodol, Phenytoin and Fosphenytoin Articles and Methods |
| 05/07/2009 | US20090118236 such as 2-[(3,5-dimethyl-4-(4'-hydroxy-3'-iso-propylbenzyl) phenoxy)methyl]-4-(3-chlorophenyl)-2-oxo-2 lambda 5-[1,3,2]-dioxaphosphonane, used for preventing and/or treating metabolic disorders such as obesity, hypercholesterolemia and hyperlipidemia |
| 05/07/2009 | US20090118235 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 05/07/2009 | US20090118234 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 05/07/2009 | US20090118233 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 05/07/2009 | US20090118232 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 05/07/2009 | US20090118231 prepared by an enzymatic reaction by pectinesterase to cross-link pectin with starch, both of which are natural and belonging to GRAS (generally recognized as safe) substances; useful in food products, including nutritional supplements, to reduce calorie content and increase fiber content |
| 05/07/2009 | US20090118230 Fucose containing proteoglycan or acidic glycan and their pharmaceutical use |
| 05/07/2009 | US20090118229 Carotenoid-containing compositions and methods |
| 05/07/2009 | US20090118228 Carotenoid-containing compositions and methods |
| 05/07/2009 | US20090118227 Carotenoid-containing compositions and methods |
| 05/07/2009 | US20090118226 Intestinal eosinophil-suppressing composition |
| 05/07/2009 | US20090118225 1-Methyl Nicotinamide and Derivatives for Treatment of Gastric Injury |
| 05/07/2009 | US20090118224 Agent against psychosocial stresses |
| 05/07/2009 | US20090118223 Novel 2'-c-methyl and 4'c-methyl nucleoside derivatives |
| 05/07/2009 | US20090118222 Novel pyrimidine nucleoside compound or its salt |
| 05/07/2009 | US20090118221 Method of treating arrhythmias |
| 05/07/2009 | US20090118220 Substituted adenines and the uses thereof |
| 05/07/2009 | US20090118218 Biocompatible Hydrogels |
| 05/07/2009 | US20090118217 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders |
| 05/07/2009 | US20090118216 Anaplastic lymphoma kinase (alk) as oncoantigen for lymphoma vaccination |
| 05/07/2009 | US20090118215 Bioresorbable Controlled-Release Composition |
| 05/07/2009 | US20090118214 Compositions for conferring tolerance to viral disease in social insects, and the use thereof |
| 05/07/2009 | US20090118213 Rna antagonist compounds for the inhibition of apo-b100 expression |
| 05/07/2009 | US20090118212 Methods for producing and using in vivo pseudotyped retroviruses |
| 05/07/2009 | US20090118211 Compositions and Methods for Enhancement of Sexual Function |
| 05/07/2009 | US20090118209 Use of the slug gene as a genetic marker in functions mediated by SCF (stem cell factor) and applications |
| 05/07/2009 | US20090118208 Composition and methods of RNAI therapeutics for treatment of cancer and other neovascularization diseases |
| 05/07/2009 | US20090118207 Use of apoptosis-specific eIF-5A siRNA to down regulate expression of proinflammatory cytokines to treat sepsis |
| 05/07/2009 | US20090118206 Rna interference for the treatment of gain-of-function disorders |
| 05/07/2009 | US20090118205 Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and uses Thereof in the Treatment of Cancer |
| 05/07/2009 | US20090118204 Methods and Compositions Related to Esculentoside A |
| 05/07/2009 | US20090118203 Administration of agents inducing dopachrome tautomerase (TRP-2) expression for protecting hair follicle melanocytes |
| 05/07/2009 | US20090118202 Compositions and methods of treating hypertension with tannin complexes |
| 05/07/2009 | US20090118201 Benzylbenzene derivatives and methods of use |
| 05/07/2009 | US20090118200 Proline bis-amide orexin receptor antagonists |
| 05/07/2009 | US20090118199 Substituted acrylamide derivative and pharmaceutical composition comprising the same |
| 05/07/2009 | US20090118192 sequentially administering parathyroid hormone and bone resorption inhibitor; bone disorders; osteoporosis |
| 05/07/2009 | US20090118187 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/07/2009 | US20090118176 Stem Cell Factor-Like Protein Scfa1 and Uses Thereof |
| 05/07/2009 | US20090118175 Compositions and Methods for Detection, Prognosis and Treatment of Breast Cancer |
| 05/07/2009 | US20090118174 Novel peptides and methods for the treatment of inflammatory disorders |
| 05/07/2009 | US20090118171 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 05/07/2009 | US20090118170 Buccal, polar and non-polar spray or capsule |
| 05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
| 05/07/2009 | US20090118168 Topical adminstration of acyclovir |
| 05/07/2009 | US20090118164 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090118159 glucokinase activator 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide or a salt thereof; chemical synthesis to obtain antidiabetic agent |
| 05/07/2009 | US20090117588 Methods of diagnosing pre-eclampsia or eclampsia |
| 05/07/2009 | US20090117586 Fungal cell wall synthesis gene |
| 05/07/2009 | US20090117566 Compositions and methods for the diagnosis and treatment of tumor |
| 05/07/2009 | US20090117565 Compositions and methods for diagnosis and treating mood disorders |
| 05/07/2009 | US20090117406 Concentrate for film preservation |
| 05/07/2009 | US20090117232 Lipoic acid pellets |
| 05/07/2009 | US20090117216 treating obesity, diabetes, inflammation, or cancer in a mammal with a biosynthesized protein from culturing microorganisms of algae or bacteria; viral infections, oxidative stress, cardiovascular diseases, immune system disorders, metabolic disorders, HIV, or gastric reflux disease |
| 05/07/2009 | US20090117215 Extract of ceratonia siliqua leaves and pods containing polyphenols with antioxidant and antitumor activities |
| 05/07/2009 | US20090117214 Extract Of Fraxinus Excelsior Seeds And Therapeutic Applications Therefor |
| 05/07/2009 | US20090117210 Andrographis paniculata extract |
| 05/07/2009 | US20090117208 Amino acid composition and supplementary liquid containing the same |
| 05/07/2009 | US20090117207 Methods and compositions for treatment of poison-caused pathology |
| 05/07/2009 | US20090117205 Quinolone-containing medicinal composition |
| 05/07/2009 | US20090117204 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
| 05/07/2009 | US20090117203 Kit for cancer treatment and pharmaceutical composition for cancer treatment |
| 05/07/2009 | US20090117201 Multi-purpose acid compositions |
| 05/07/2009 | US20090117197 Compositions and methods for ameliorating cachexia |
| 05/07/2009 | US20090117195 Hydrophilic Particles Based on Cationic Chitosan Derivatives |
| 05/07/2009 | US20090117194 Eukaryotic microorganisms for producing lipids and antioxidants |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117192 Composition for transdermal absorption and formulation comprising a polymeric matrix formed therefrom |
| 05/07/2009 | US20090117191 Controlled release tramadol formulations |
| 05/07/2009 | US20090117190 Sustained-release preparation |
| 05/07/2009 | US20090117188 Methods of Augmenting or Repairing Soft Tissue |
| 05/07/2009 | US20090117186 Trofosfamide-containing film-coated tablets and method for the production thereof |
| 05/07/2009 | US20090117184 Use of a gestagen in combination with an estrogen and one or more pharmaceutically acceptable auxiliary agents/excipients for lactose-free oral contraception |
| 05/07/2009 | US20090117183 Oral contraceptive containing a gestagen and an estrogen combined with pharmaceutically acceptable auxiliary agents and/or excipients, but not containing lactose, and method of making same |
| 05/07/2009 | US20090117181 Tablet comprising fluvastatin and carmellose calcium |
| 05/07/2009 | US20090117179 siDNA against Influenza Virus |